David Hathorn

发表

SPIRE – combining SGI-110 with cisplatin and gemcitabine chemotherapy for solid malignancies including bladder cancer: study protocol for a phase Ib/randomised IIa open label clinical trial

R. Huddart, J. Catto, S. Crabb, 2018, Trials.